By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mologen AG 

P.O. Box 332140

Berlin    D - 14180  Germany
Phone: 49-0-30-857-576-0 Fax: 49-0-30-857-576-50


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy





Company News
The Chairman Of The Supervisory Board Of Mologen AG (MOLGF.PK) Resigns From His Office As Board Member And Chairman And Is Nominated For Re-Election 6/18/2015 12:26:49 PM
Mologen AG (MOLGF.PK): First Patient Enrolled In TEACH Study To Treat HIV Patients With MGN1703 6/3/2015 8:15:55 AM
Mologen AG (MOLGF.PK) To Present Poster At ASCO Annual Meeting 5/27/2015 9:57:44 AM
Mologen AG (MOLGF.PK): Progress In Clinical Trials Sets First Quarter Trend 5/12/2015 8:44:23 AM
Mologen AG (MOLGF.PK): Aarhus University Hospital Initiates MGN1703 Study In HIV Patients 5/8/2015 8:50:09 AM
Mologen AG (MOLGF.PK) Presented Data Supporting The Administration Scheme Of MGN1703 At ITOC-2 Conference 2015 3/30/2015 9:08:25 AM
Mologen AG (MOLGF.PK): Start Of Pivotal Study For Cancer Immunotherapy MGN1703 Influences 2014 Annual Result 3/25/2015 9:56:22 AM
Mologen AG (MOLGF.PK) Presented Subgroup Analysis From IMPACT Study And Design Of Pivotal IMPALA Trial At Gastrointestinal Cancers Symposium 2015 1/19/2015 10:13:03 AM
Mologen AG (MOLGF.PK): Presentation On IMPACT Study At ESMO Symposium On Immuno-Oncology 11/17/2014 1:27:53 PM
Mologen AG (MOLGF.PK) Publishes Nine Month Report For 2014: Launch Of Pivotal Study For The Cancer Immunotherapy MGN1703 11/13/2014 9:51:51 AM
123456789
//-->